Cronos Group Inc.
Every calculator, already run for CRON
Open the full toolkit →You have the numbers on CRON. Get the argument.
A written report on which of these readings actually decide the outcome for Cronos Group Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
4 analysts covering CRONOwnership & short interest
Insider Trading Activity for CRON
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
CRON — frequently asked
Is CRON a buy right now?
Wall Street's consensus rating on Cronos Group Inc. is none across 4 analysts, with a mean price target of $2.51 (-25% vs. the current $3.35). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CRON overvalued?
CRON trades at 17.6x trailing earnings, against a DCF fair value of $0 per share. The current price implies 42% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CRON's next earnings date?
Cronos Group Inc. is next scheduled to report earnings around Nov 5, 2026. A full CRON research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare Cronos Group Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Cronos Group Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CRON research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Cronos Group Inc., in minutes. 3 free reports included with every account — no credit card required.